Levonorgestrel-Releasing Intrauterine System (LNG-IUS) in the Management of Atypical Endometrial Hyperplasia

NCT04897217 · clinicaltrials.gov ↗

PHASE3

Phase

WITHDRAWN

Status

OTHER

Sponsor class

Stopped PI decision

Conditions

Endometrial Hyperplasia

Interventions

DRUG: Megestrol Acetate
DRUG: Levonorgestrel Drug Implant

Sponsor

Wake Forest University Health Sciences

Collaborators

[object Object]